ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Vistagen Therapeutics Inc

Vistagen Therapeutics Inc (VTGN)

2.7472
0.0922
( 3.47% )
Updated: 13:53:48

Vistagen Therapeutics Inc Financial Summary

The current VTGN market cap is 79.29M. The company's latest EPS is USD -1.0173 and P/E is -2.61.

Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 412k197k84k183k234k
Operating Income -7.88M-11.36M-12.13M-14.23M-15.12M
Net Income -6.35M-9.52M-10.73M-12.96M-14.09M
Year End March 30 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 01.09M1.11M-227k1.06M
Operating Income -20.8M-17.93M-47.78M-59.27M-33.02M
Net Income -22.04M-42.32M-48.71M-59.25M-29.36M
Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 131.07M123.65M113.55M102.5M92.31M
Total Liabilities 7.78M9.37M8.75M9.52M11.19M
Total Equity 123.29M114.29M104.8M92.97M81.12M
Year End March 30 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 5.77M108.28M74.64M21.09M123.65M
Total Liabilities 11.5M16.3M9.93M9.01M9.37M
Total Equity -5.73M91.98M64.72M12.08M114.29M
Quarter End Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -18.62M-25.81M-10.87M-21.76M-32.04M
Investing -32k-61k-5.47M-13.25M-13.68M
Financing 128.57M128.4M88k88k1.26M
Year End March 30 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -15.76M-12.07M-45.26M-49.72M-25.81M
Investing N/A -275k-200k-740k-61k
Financing 4.01M114.1M10.48M-1.04M128.4M
Market Cap 79.29M
Price to Earnings Ratio -2.61
Price to Sales Ratio 72.09
Price to Cash Ratio 0.64
Price to Book Ratio 0.67
Dividend Yield -

Share Statistics

Shares Outstanding 28.86M
Average Volume (1 week) 158.68k
Average Volume (1 Month) 164.48k
52 Week Change -34.43%
52 Week High 5.74
52 Week Low 2.22
Spread (Intraday) 0.03 (1.09%)

Company Info

Company Name Vistagen Therapeutics Inc
Address 701 s carson st
carson city, nevada 89701
Website https://www.vistagen.com
Industry pharmaceutical preparations (2834)